An innovative online tool funded by NIBIB helps organizations choose a COVID-19 testing strategy that will work best for their specific needs.
2021 is finally here and most of us are thrilled to put last year in the rear-view mirror. Although the rollercoaster month of January hasn’t been the smoothest of starts, there are many positive signs that a brighter future is just around the corner.
Several months ago in this space I wrote that bioengineered technologies for COVID-19 testing must ultimately be deployed to help reduce the spread of the virus and return us safely to full function as a society. Since then, through a massive response by the bioengineering community in support of the RADx initiative, we have awarded contracts worth $ 513.1 million to 25 small and large biomedical diagnostic companies for scale-up and manufacturing.